Annual Working Capital
$21.48 M
-$32.28 M-60.05%
31 December 2023
Summary:
INmune Bio annual working capital is currently $21.48 million, with the most recent change of -$32.28 million (-60.05%) on 31 December 2023. During the last 3 years, it has fallen by -$733.00 thousand (-3.30%). INMB annual working capital is now -72.55% below its all-time high of $78.25 million, reached on 31 December 2021.INMB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$22.03 M
+$1.58 M+7.75%
30 September 2024
Summary:
INmune Bio quarterly working capital is currently $22.03 million, with the most recent change of +$1.58 million (+7.75%) on 30 September 2024. Over the past year, it has dropped by -$9.23 million (-29.52%). INMB quarterly working capital is now -74.42% below its all-time high of $86.12 million, reached on 30 September 2021.INMB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INMB Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.0% | -29.5% |
| 3 y3 years | -3.3% | -74.4% |
| 5 y5 years | +10000.0% | +169.7% |
INMB Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.5% | at low | -74.4% | +78.0% |
| 5 y | 5 years | -72.5% | >+9999.0% | -74.4% | +328.4% |
| alltime | all time | -72.5% | >+9999.0% | -74.4% | >+9999.0% |
INmune Bio Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.03 M(+7.7%) |
| June 2024 | - | $20.44 M(+65.2%) |
| Mar 2024 | - | $12.37 M(-42.4%) |
| Dec 2023 | $21.48 M(-60.0%) | $21.48 M(-31.3%) |
| Sept 2023 | - | $31.25 M(-21.0%) |
| June 2023 | - | $39.55 M(-15.1%) |
| Mar 2023 | - | $46.60 M(-13.3%) |
| Dec 2022 | $53.76 M(-31.3%) | $53.76 M(-10.0%) |
| Sept 2022 | - | $59.76 M(-12.4%) |
| June 2022 | - | $68.26 M(-7.5%) |
| Mar 2022 | - | $73.83 M(-5.6%) |
| Dec 2021 | $78.25 M | $78.25 M(-9.1%) |
| Sept 2021 | - | $86.12 M(+109.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $41.06 M(-12.7%) |
| Mar 2021 | - | $47.02 M(+111.7%) |
| Dec 2020 | $22.21 M(+214.4%) | $22.21 M(-9.9%) |
| Sept 2020 | - | $24.66 M(+379.7%) |
| June 2020 | - | $5.14 M(-12.3%) |
| Mar 2020 | - | $5.86 M(-17.0%) |
| Dec 2019 | $7.06 M(>+9900.0%) | $7.06 M(-13.5%) |
| Sept 2019 | - | $8.17 M(-20.6%) |
| June 2019 | - | $10.29 M(+62.1%) |
| Mar 2019 | - | $6.35 M(>+9900.0%) |
| Dec 2018 | $25.50 K(-98.4%) | $25.50 K(-97.3%) |
| Sept 2018 | - | $953.00 K(-40.1%) |
| Dec 2017 | $1.59 M(-1165.5%) | $1.59 M |
| Dec 2016 | -$149.20 K | - |
FAQ
- What is INmune Bio annual working capital?
- What is the all time high annual working capital for INmune Bio?
- What is INmune Bio annual working capital year-on-year change?
- What is INmune Bio quarterly working capital?
- What is the all time high quarterly working capital for INmune Bio?
- What is INmune Bio quarterly working capital year-on-year change?
What is INmune Bio annual working capital?
The current annual working capital of INMB is $21.48 M
What is the all time high annual working capital for INmune Bio?
INmune Bio all-time high annual working capital is $78.25 M
What is INmune Bio annual working capital year-on-year change?
Over the past year, INMB annual working capital has changed by -$32.28 M (-60.05%)
What is INmune Bio quarterly working capital?
The current quarterly working capital of INMB is $22.03 M
What is the all time high quarterly working capital for INmune Bio?
INmune Bio all-time high quarterly working capital is $86.12 M
What is INmune Bio quarterly working capital year-on-year change?
Over the past year, INMB quarterly working capital has changed by -$9.23 M (-29.52%)